Recent Updates
Recently added Catalysts
KPTI

Karyopharm to Participate at the Barclays Global Healthcare Conference

Key Takeaway: NEWTON, Mass., March 9, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate in a fireside chat at the Barclays Glo
Price reaction · baseline $89.25 (2022-03-08 close) · hit after-hours · 1 other KPTI headline(s) in the window, move may be shared
day 0 close · peak
+10.6%
day 1
+9.1%
day 3
+2.4%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+105%
120-day peak, hindsight
Typical move
15.1%
average across 5 past catalysts
Cash runway
~8 mo
Medium dilution risk
Lead asset
Selinexor
Phase 2 · Acute Myeloid Leukemia (AML)

Full Press Release Details

NEWTON, Mass., March 9, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate in a fireside chat at the Barclays Global Healthcare Conference. The conference is being held in Miami, Florida and the fireside chat will take place on Wednesday, March 16, 2022 at 10:15 a.m. ET.
A live webcast of the fireside chat, along with accompanying slides, can be accessed under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations, and will be available for replay for 90 days following the event.
About Karyopharm Therapeutics
XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc. Any other trademarks referred to in this release are the property of their respective owners.
Last updated: Mar 9, 2022